Clinical trials
Peptic Ulcer trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 2 |
| RenJi Hospital | 2 |
| Taipei Veterans General Hospital, Taiwan | 2 |
| Ajou University School of Medicine | 1 |
| Asan Medical Center | 1 |
| Dong-A ST Co., Ltd. | 1 |
| Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 1 |
| Hadassah Medical Organization | 1 |
| Hamilton Health Sciences Corporation | 1 |
| LumeRx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peptic Ulcer | 22 |
| Stomach Neoplasms | 5 |
| Dyspepsia | 3 |
| Gastroesophageal Reflux | 3 |
| Esophageal Neoplasms | 2 |
| Esophagitis | 2 |
| Gastritis | 2 |
| Hemorrhage | 2 |
| Peptic Ulcer Hemorrhage | 2 |
| Anxiety Disorders | 1 |
Trials
Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.